iHuman (IH) Competitors

iHuman logo
$1.40 +0.03 (+1.82%)
As of 03:36 PM Eastern

IH vs. JDZG, TONX, NRDY, HCMA, and CHGG

Should you buy iHuman stock or one of its competitors? MarketBeat compares iHuman with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with iHuman include JIADE (JDZG), Verb Technology (TONX), Nerdy (NRDY), HCM Acquisition (HCMA), and Chegg (CHGG). These companies are all part of the "personal services" industry.

How does iHuman compare to JIADE?

JIADE (NASDAQ:JDZG) and iHuman (NYSE:IH) are both small-cap consumer discretionary companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, media sentiment, valuation and analyst recommendations.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
JIADE
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
iHuman
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

iHuman has a net margin of 11.80% compared to JIADE's net margin of 0.00%. iHuman's return on equity of 9.79% beat JIADE's return on equity.

Company Net Margins Return on Equity Return on Assets
JIADEN/A N/A N/A
iHuman 11.80%9.79%6.99%

iHuman has higher revenue and earnings than JIADE.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
JIADE$3.67M73.98-$1.51MN/AN/A
iHuman$115.40M0.62$13.64M$0.255.58

JIADE has a beta of 2.07, meaning that its stock price is 107% more volatile than the broader market. Comparatively, iHuman has a beta of 0.14, meaning that its stock price is 86% less volatile than the broader market.

4.9% of iHuman shares are owned by institutional investors. 63.6% of iHuman shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, JIADE's average media sentiment score of 0.00 equaled iHuman'saverage media sentiment score.

Company Overall Sentiment
JIADE Neutral
iHuman Neutral

Summary

iHuman beats JIADE on 7 of the 9 factors compared between the two stocks.

How does iHuman compare to Verb Technology?

Verb Technology (NASDAQ:TONX) and iHuman (NYSE:IH) are both small-cap personal services companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings.

In the previous week, Verb Technology's average media sentiment score of 0.00 equaled iHuman'saverage media sentiment score.

Company Overall Sentiment
Verb Technology Neutral
iHuman Neutral

iHuman has higher revenue and earnings than Verb Technology. Verb Technology is trading at a lower price-to-earnings ratio than iHuman, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Verb Technology$12.78M13.09-$148.48M-$2.84N/A
iHuman$115.40M0.62$13.64M$0.255.58

7.2% of Verb Technology shares are owned by institutional investors. Comparatively, 4.9% of iHuman shares are owned by institutional investors. 21.4% of Verb Technology shares are owned by insiders. Comparatively, 63.6% of iHuman shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

iHuman has a net margin of 11.80% compared to Verb Technology's net margin of -1,416.59%. iHuman's return on equity of 9.79% beat Verb Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Verb Technology-1,416.59% -78.40% -76.10%
iHuman 11.80%9.79%6.99%

Verb Technology has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market. Comparatively, iHuman has a beta of 0.14, meaning that its stock price is 86% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Verb Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
iHuman
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

iHuman beats Verb Technology on 8 of the 11 factors compared between the two stocks.

How does iHuman compare to Nerdy?

Nerdy (NYSE:NRDY) and iHuman (NYSE:IH) are both small-cap consumer discretionary companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, media sentiment, risk and dividends.

iHuman has a net margin of 11.80% compared to Nerdy's net margin of -18.60%. iHuman's return on equity of 9.79% beat Nerdy's return on equity.

Company Net Margins Return on Equity Return on Assets
Nerdy-18.60% -93.27% -45.70%
iHuman 11.80%9.79%6.99%

iHuman has lower revenue, but higher earnings than Nerdy. Nerdy is trading at a lower price-to-earnings ratio than iHuman, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nerdy$180.13M0.92-$39.92M-$0.28N/A
iHuman$115.40M0.62$13.64M$0.255.58

39.1% of Nerdy shares are held by institutional investors. Comparatively, 4.9% of iHuman shares are held by institutional investors. 51.5% of Nerdy shares are held by company insiders. Comparatively, 63.6% of iHuman shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Nerdy presently has a consensus price target of $1.00, indicating a potential upside of 14.65%. Given Nerdy's stronger consensus rating and higher probable upside, analysts clearly believe Nerdy is more favorable than iHuman.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nerdy
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
iHuman
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Nerdy had 4 more articles in the media than iHuman. MarketBeat recorded 4 mentions for Nerdy and 0 mentions for iHuman. Nerdy's average media sentiment score of 1.07 beat iHuman's score of 0.00 indicating that Nerdy is being referred to more favorably in the media.

Company Overall Sentiment
Nerdy Positive
iHuman Neutral

Nerdy has a beta of 1.76, indicating that its share price is 76% more volatile than the broader market. Comparatively, iHuman has a beta of 0.14, indicating that its share price is 86% less volatile than the broader market.

Summary

Nerdy beats iHuman on 8 of the 15 factors compared between the two stocks.

How does iHuman compare to HCM Acquisition?

iHuman (NYSE:IH) and HCM Acquisition (NASDAQ:HCMA) are both small-cap personal services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and profitability.

iHuman has higher revenue and earnings than HCM Acquisition.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
iHuman$115.40M0.62$13.64M$0.255.58
HCM AcquisitionN/AN/AN/AN/AN/A

iHuman has a net margin of 11.80% compared to HCM Acquisition's net margin of 0.00%. iHuman's return on equity of 9.79% beat HCM Acquisition's return on equity.

Company Net Margins Return on Equity Return on Assets
iHuman11.80% 9.79% 6.99%
HCM Acquisition N/A N/A N/A

4.9% of iHuman shares are held by institutional investors. Comparatively, 11.8% of HCM Acquisition shares are held by institutional investors. 63.6% of iHuman shares are held by insiders. Comparatively, 71.2% of HCM Acquisition shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

iHuman has a beta of 0.14, suggesting that its share price is 86% less volatile than the broader market. Comparatively, HCM Acquisition has a beta of -0.27, suggesting that its share price is 127% less volatile than the broader market.

In the previous week, iHuman's average media sentiment score of 0.00 equaled HCM Acquisition'saverage media sentiment score.

Company Overall Sentiment
iHuman Neutral
HCM Acquisition Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
iHuman
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
HCM Acquisition
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

iHuman beats HCM Acquisition on 5 of the 7 factors compared between the two stocks.

How does iHuman compare to Chegg?

Chegg (NYSE:CHGG) and iHuman (NYSE:IH) are both small-cap personal services companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends, risk and media sentiment.

In the previous week, Chegg had 2 more articles in the media than iHuman. MarketBeat recorded 2 mentions for Chegg and 0 mentions for iHuman. Chegg's average media sentiment score of 0.16 beat iHuman's score of 0.00 indicating that Chegg is being referred to more favorably in the media.

Company Overall Sentiment
Chegg Neutral
iHuman Neutral

95.2% of Chegg shares are held by institutional investors. Comparatively, 4.9% of iHuman shares are held by institutional investors. 3.0% of Chegg shares are held by insiders. Comparatively, 63.6% of iHuman shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

iHuman has lower revenue, but higher earnings than Chegg. Chegg is trading at a lower price-to-earnings ratio than iHuman, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chegg$376.91M0.32-$103.42M-$0.79N/A
iHuman$115.40M0.62$13.64M$0.255.58

Chegg has a beta of 2.17, suggesting that its stock price is 117% more volatile than the broader market. Comparatively, iHuman has a beta of 0.14, suggesting that its stock price is 86% less volatile than the broader market.

iHuman has a net margin of 11.80% compared to Chegg's net margin of -26.89%. iHuman's return on equity of 9.79% beat Chegg's return on equity.

Company Net Margins Return on Equity Return on Assets
Chegg-26.89% -6.73% -2.81%
iHuman 11.80%9.79%6.99%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Chegg
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.33
iHuman
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

iHuman beats Chegg on 8 of the 15 factors compared between the two stocks.

Get iHuman News Delivered to You Automatically

Sign up to receive the latest news and ratings for IH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IH vs. The Competition

MetriciHumanSCHOOLS IndustryDiscretionary SectorNYSE Exchange
Market Cap$70.02M$1.40B$7.15B$23.26B
Dividend YieldN/A2.57%3.09%4.07%
P/E Ratio5.5810.7720.4231.08
Price / Sales0.623.814.0421.86
Price / Cash4.7513.1815.1824.45
Price / Book0.502.293.704.64
Net Income$13.64M$78.99M$247.03M$1.07B
7 Day Performance1.09%1.49%-1.22%-1.04%
1 Month Performance-13.08%-0.43%0.08%0.18%
1 Year Performance-40.51%-18.09%4.06%24.25%

iHuman Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IH
iHuman
0.7744 of 5 stars
$1.40
+1.8%
N/A-40.8%$70.02M$115.40M5.581,120
JDZG
JIADE
0.3411 of 5 stars
$50.00
flat
N/AN/A$271.50M$3.67MN/AN/A
TONX
Verb Technology
0.6638 of 5 stars
$3.43
+0.8%
N/AN/A$193.79M$16.73MN/A170
NRDY
Nerdy
2.2732 of 5 stars
$0.91
+7.9%
$1.00
+10.4%
-42.8%$172.24M$178.99MN/A700
HCMA
HCM Acquisition
N/A$10.27
-0.1%
N/A+1.7%$145.20MN/AN/AN/A

Related Companies and Tools


This page (NYSE:IH) was last updated on 6/23/2026 by MarketBeat.com Staff.
From Our Partners